Utrecht Holdings
Utrecht Holdings is an investment fund investing in Netherlands and Europe, focused on Biotech, Deep Tech, Healthcare and AI. They write Pre-seed and Seed cheques. We hold 12 investments for them on record. 8 people are listed at the firm.
utrechtholdings.nl- Sectors
- BiotechDeep TechHealthcareAI
- Geographies
- NetherlandsEurope
- Cheque size
- Not on record
What Utrecht Holdings invests in
Supports university researchers turning inventions into therapies, sustainable materials, and AI applications via patents, licensing, venture creation, and early funding.
People at Utrecht Holdings
8 named people on record.
- Anna Degena•••••@utrechtholdings.nl
- Arjen Vanvlieta•••••@utrechtholdings.nl
Contact addresses at Utrecht Holdings are partly hidden. Create a free account to see full addresses, a fit score against your own startup, and an outreach email written for this investor.
6 more people at Utrecht Holdings.
The first two are open to everyone. A free account opens the rest — their names, roles and full contact addresses. No card, no demo call.
Utrecht Holdings portfolio
12 investments on record. Each row says whether the round came from the fund's own portfolio page or from the press, so you can check it.
| Company | Sector | Round | Amount | Date |
|---|---|---|---|---|
| HealthcareNetherlands | — | — | —their site | |
| HealthcareNetherlands | — | — | —their site |
10 more investments on record for Utrecht Holdings.
The first two are open to everyone. A free account opens the rest — the company, the round, the amount, the date and where each number came from. No card, no demo call.
Investors similar to Utrecht Holdings
212Backs B2B tech startups ready to scale globally, leveraging a vast network across…
Portfolio VenturesBacks fintech, B2B software, and verticalised AI at seed, leveraging a network of top…
Or browse the whole directory.
Write to Utrecht Holdings with something they'll read.
Pitch2Fund scores your startup against Utrecht Holdings's actual thesis and portfolio, then writes the email — citing the companies they've already backed and why yours fits beside them. Free, and you keep the contacts.